Stock analysts at StockNews.com started coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a report released on Tuesday. The firm set a “sell” rating on the basic materials company’s stock.
Arcadia Biosciences Stock Performance
NASDAQ RKDA opened at $4.80 on Tuesday. The company has a market cap of $6.55 million, a PE ratio of -1.12 and a beta of 0.88. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $10.31. The stock’s 50-day moving average price is $5.40 and its two-hundred day moving average price is $3.90.
Arcadia Biosciences Company Profile
Read More
- Five stocks we like better than Arcadia Biosciences
- P/E Ratio Calculation: How to Assess Stocks
- Merck: 4 No-Brainer Reasons to Buy This Dip
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.